🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to estimate the risk of bleeding with rivaroxa...
Status
Completed
Location
Multiple Locations
Start Date
2015-04-20
Trial ID
NCT02293395
Treatments Being Tested
The primary objective of this study is to assess the pharmacodynamic (PD) e...
Status
Completed
Location
Biotrial Inc
Start Date
2018-01-24
Trial ID
NCT03430661
Treatments Being Tested
Rationale: Acute coronary syndrome (ACS) is the leading cause of death worl...
Status
Recruiting
Location
Gelre Ziekenhuizem
Start Date
2015-01-01
Trial ID
NCT03823547
Rationale: the use of antiplatelet drugs (i.e. clopidogrel, ticagrelor or p...
Status
Completed
Location
OLV Hospital
Start Date
2011-06
Trial ID
NCT01761786
Treatments Being Tested
The ASET Japan Pilot study is a multicenter, single arm, open-label trial o...
Status
Active Not Recruiting
Location
CORRIB Research Centre for Advanced Imaging and Core laboratoryNational University of Ireland, Galway
Start Date
2020-09-15
Trial ID
NCT05117866
Treatments Being Tested
Polymorphisms of the cytochrome P450 (CYP) 2C19 enzyme has been consistentl...
Status
Completed
Location
University of Florida
Start Date
2018-05-30
Trial ID
NCT03489863
Treatments Being Tested
The purpose of this study is to see if one month of dual antiplatelet thera...
Status
Terminated
Location
HonorHealth Research Institute
Start Date
2018-11-19
Trial ID
NCT03606642
Treatments Being Tested
The goal of this clinical trial is to learn if reducing the duration of dua...
Status
Not Yet Recruiting
Location
Caen University Hospital
Start Date
2025-10
Trial ID
NCT07164859
Treatments Being Tested
Prasugrel and ticagrelor were both associated with a significant reduction ...
Status
Completed
Location
Multiple Locations
Start Date
2015-01
Trial ID
NCT01967615
The selection of the optimal antithrombotic therapy in patients with nonval...
Status
Completed
Location
Medizinische Universität Innsbruck Universitätsklinik für Innere Medizin III - Kardiologie und Angiologie Anichstraße 35 6020 Innsbruck, Austria
Start Date
2021-12-16
Trial ID
NCT04981041
Treatments Being Tested